A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »
mypharmacynews.com
Home »
A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »The current COVID-19 outbreak is one of the worst pandemics in history and has claimed millions of lives across the
Continue reading »Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The
Continue reading »The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen successfully uses multiple immune evasion mechanisms to achieve infection within its
Continue reading »A study recently conducted at the Jenner Institute, University of Oxford, UK, has investigated the significance of a transmembrane glycoprotein
Continue reading »Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic has placed a significant
Continue reading »